Biopharma Sales Compensation Plan Diagnostic
What Does a SCOR³ES® Diagnostic Entail?
A SCOR³ES® Diagnostic is a comprehensive analysis of your current IC plan. A SCOR³ES® Diagnostic includes:
Overall SCOR³ES® Rating
SCOR³ES® Rating for each of the 6 Criteria and 4 Tests of Equity
Detailed PROs, CONs, and How to Improve your plan design for each of the 6 Criteria and 4 Tests of Equity
Specific recommendations tailored to your product(s) to improve your current plan design
What is the SCOR³ES® Diagnostic?
Developed over 20 years ago exclusively for the pharma, biotech and medical device industries, SCOR³ES® is a biopharma sales incentive compensation diagnostic that quantifies the performance of sales incentive compensation plans against six critical criteria of plan effectiveness, including four patent-pending tests of equity.
SCOR³ES® Correlation With Sales
What makes SCOR³ES® so powerful is that over the years, the SCOR³ES® rating system has been fine-tuned such that improvements in SCOR³ES® ratings have been statistically shown to be correlated with increases in sales, demonstrating that replacing a poor sales incentive compensation plan with a good one can increase sales anywhere from 7%-18%.
Evaluating a Sales Compensation Plan’s Effectiveness: SCOR³ES®
Designing Compensation Plans that Drive Sales
Clients We’ve Served
Join the companies that have revolutionized their sales compensation and sales optimization strategy with The Marketing Advantage, from small start-ups to multi-national corporations.
Learn More About Our Sales Compensation Solutions
Goal Setting
See how we maximize goal accuracy through customizing goal setting to each client’s unique needs and conditions.
Launch Sales Compensation
Achieve fast adoption and secure your new product’s position in the marketplace with our proven launch sales compensation strategies.
Rare Disease Sales Compensation
We design sales compensation plans for rare disease products that maximize the product’s ability to reach as many patients as possible.
